human notch1 icd Search Results


96
Cell Signaling Technology Inc against n1 icd
Against N1 Icd, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+notch1+icd/Cleaved+Notch1+(Val1744)+Rabbit+mAb/bio_rxiv__2024__12__13__628320-253-10-7
Average 96 stars, based on 1 article reviews
against n1 icd - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc rabbit antihuman notch1 icd antibody
Rabbit Antihuman Notch1 Icd Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+notch1+icd/Notch1+XP+Rabbit+mAb/ppr0231070-93-36-42
Average 96 stars, based on 1 article reviews
rabbit antihuman notch1 icd antibody - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

93
Addgene inc human notch1 intracellular domain
Figure 4. Sox17 expression is inversely regulated by Notch signaling. A, Immunofluorescence images for Sox17 (red) and green fluorescent protein (GFP; green) of human umbilical vein endothelial cells transfected with mock (control) or <t>Notch1</t> intracellular domain (N1ICD) vector, which can express GPF simultaneously by a dual promoter system. Transfected cells are distinguished as GFP expression. Arrows highlight reduced Sox17 protein expression only in individual cells transfected with N1ICD vector but not in nontransfected cells. (B) Quantification of Sox17 protein expression in A. Images for Sox17 (red) and isolectin-B4 (IB4; green) of P5 retina. (C) Reduced Sox17 expression in N1ICDiGOF mutants. D, Increased Sox17- expressing endothelial cells on α-delta–like ligand 4 (Dll4) antibody treatment compared with IgG treatment. Scale bars, 100 μm. Ctrl indicates control.
Human Notch1 Intracellular Domain, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+notch1+icd/Notch1+intracellular+domain-pcw107+(Plasmid+%2364621)/10__1161_slash_circresaha__115__303142-54-26-34
Average 93 stars, based on 1 article reviews
human notch1 intracellular domain - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Addgene inc human notch1 intracellular domain plasmid
NO sustains CSC stemness through the activation of <t>Notch1.</t> (A) Immunoblot analysis of Notch1 and Hes1 protein in non‐CSCs and CSCs. (B) The protein expression of Notch1 was analysed in non‐CSCs treated with DETA NONOate (20 μM) for 24 h. (C) CSCs were treated with L‐NAME for 24 h and detected for Notch1 protein with immunoblots. (D, E) CSCs were treated with L‐NAME (100 μM)/1400 W (100 μM) in the presence or absence of the DETA NONOate (20 μM)/GSNO (200 μM) for 24 h. Protein expression of Notch1 and Hes1 were detected by immunoblot. (F–H) CSCs were exposed to L‐NAME (100 μM) with or without the reintroduction of <t>NICD</t> and were analysed for expression of Notch1 protein, stem‐related transcripts and spheres formation. Mean ± SEM from 5 to 9 independent experiments. * p < 0.05, ** p < 0.01 and *** p < 0.001 with paired t ‐test (B, C), unpaired t ‐test (A) and ANOVA plus Turkey's method (D, G, H).
Human Notch1 Intracellular Domain Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+notch1+icd/pB-TAG-NICD+(Plasmid+%23130934)/pmc11550923-36-0-8
Average 93 stars, based on 1 article reviews
human notch1 intracellular domain plasmid - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

92
Addgene inc human notch1 icd plasmid
NO sustains CSC stemness through the activation of <t>Notch1.</t> (A) Immunoblot analysis of Notch1 and Hes1 protein in non‐CSCs and CSCs. (B) The protein expression of Notch1 was analysed in non‐CSCs treated with DETA NONOate (20 μM) for 24 h. (C) CSCs were treated with L‐NAME for 24 h and detected for Notch1 protein with immunoblots. (D, E) CSCs were treated with L‐NAME (100 μM)/1400 W (100 μM) in the presence or absence of the DETA NONOate (20 μM)/GSNO (200 μM) for 24 h. Protein expression of Notch1 and Hes1 were detected by immunoblot. (F–H) CSCs were exposed to L‐NAME (100 μM) with or without the reintroduction of <t>NICD</t> and were analysed for expression of Notch1 protein, stem‐related transcripts and spheres formation. Mean ± SEM from 5 to 9 independent experiments. * p < 0.05, ** p < 0.01 and *** p < 0.001 with paired t ‐test (B, C), unpaired t ‐test (A) and ANOVA plus Turkey's method (D, G, H).
Human Notch1 Icd Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+notch1+icd/pLIX-hN1ICD+(Plasmid+%2391897)/pmc08222224-321-9-17
Average 92 stars, based on 1 article reviews
human notch1 icd plasmid - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc notch1 icd
NICD protein and NICD-dependent transcripts are more abundant in Fbw7-/- embryos. (A) Western blots using indicated antibodies against whole embryo lysates. The loading control (LC*) is a cross-reactive band. (B) Relative levels of <t>Notch</t> <t>1</t> mRNA by real-time PCR using SYBR-green detection of mRNA prepared from embryos and placenta of the indicated genotypes. (C) Relative levels of the Notch-dependent transcripts Hes1, Herp1, and Herp2 in Fbw7+/+ and Fbw7-/- embryos by using quantitative real-time PCR analysis as in B.
Notch1 Icd, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+notch1+icd/Notch3+Antibody/pmc00373463-89-15-17
Average 94 stars, based on 1 article reviews
notch1 icd - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc notch1 intracellular domain
NICD protein and NICD-dependent transcripts are more abundant in Fbw7-/- embryos. (A) Western blots using indicated antibodies against whole embryo lysates. The loading control (LC*) is a cross-reactive band. (B) Relative levels of <t>Notch</t> <t>1</t> mRNA by real-time PCR using SYBR-green detection of mRNA prepared from embryos and placenta of the indicated genotypes. (C) Relative levels of the Notch-dependent transcripts Hes1, Herp1, and Herp2 in Fbw7+/+ and Fbw7-/- embryos by using quantitative real-time PCR analysis as in B.
Notch1 Intracellular Domain, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+notch1+icd/PhosphoPlus+Notch1+(Cleaved%2C+Val1744)+Antibody+Duet/ppr0541758-46-24-28
Average 95 stars, based on 1 article reviews
notch1 intracellular domain - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

93
Addgene inc human notch1 intracellular domain hnicd construct
NICD protein and NICD-dependent transcripts are more abundant in Fbw7-/- embryos. (A) Western blots using indicated antibodies against whole embryo lysates. The loading control (LC*) is a cross-reactive band. (B) Relative levels of <t>Notch</t> <t>1</t> mRNA by real-time PCR using SYBR-green detection of mRNA prepared from embryos and placenta of the indicated genotypes. (C) Relative levels of the Notch-dependent transcripts Hes1, Herp1, and Herp2 in Fbw7+/+ and Fbw7-/- embryos by using quantitative real-time PCR analysis as in B.
Human Notch1 Intracellular Domain Hnicd Construct, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+notch1+icd/EF%2EhICN1%2EUbc%2EGFP+(Plasmid+%2317626)/10__1158_slash_0008___5472__can___15___1640___t-42-1-13
Average 93 stars, based on 1 article reviews
human notch1 intracellular domain hnicd construct - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Rockland Immunochemicals cleaved n1 icd
Systemic oestrogen signalling is mediated by EGFR and Notch . ( A ) Representative Western blot showing expression of cleaved (active) Notch1 <t>(N1-ICD)</t> following culture ± 1 nM 17β-estradiol ± 10 μM GSI. ( Bi ) Representative Western blot showing expression of Notch ligands in sorted MCF7 cells (left) and, where available, metastatic cells (right). ( Bii ) Densitometric analysis of three independent repeats of MCF7 sorting and of a single experiment for primary cells. Comparisons between population 1 (CSC enriched) and other populations are displayed. ( C and D ) Mammosphere formation was assessed following culture with 1 nM 17β-estradiol ± gamma secretase inhibitor (GSI) alone and in combination with gefitinib. Fold change is normalised to control, untreated cells represented as line. ( E ) Representative image of protein levels of ERK and phosphorylated (actived) ERK following culture for 48 hours in monolayer ± 10 μM GSI. Means plotted ± SEM, * P < 0.05, ** P < 0.01, *** P < 0.001 compared to E2 treated. # P < 0.05 compared to control cells.
Cleaved N1 Icd, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+notch1+icd/Anti-Notch1+(cleaved+N+terminal)+(Human/pmc03672803-44-10-13
Average 93 stars, based on 1 article reviews
cleaved n1 icd - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc full length notch
Systemic oestrogen signalling is mediated by EGFR and Notch . ( A ) Representative Western blot showing expression of cleaved (active) Notch1 <t>(N1-ICD)</t> following culture ± 1 nM 17β-estradiol ± 10 μM GSI. ( Bi ) Representative Western blot showing expression of Notch ligands in sorted MCF7 cells (left) and, where available, metastatic cells (right). ( Bii ) Densitometric analysis of three independent repeats of MCF7 sorting and of a single experiment for primary cells. Comparisons between population 1 (CSC enriched) and other populations are displayed. ( C and D ) Mammosphere formation was assessed following culture with 1 nM 17β-estradiol ± gamma secretase inhibitor (GSI) alone and in combination with gefitinib. Fold change is normalised to control, untreated cells represented as line. ( E ) Representative image of protein levels of ERK and phosphorylated (actived) ERK following culture for 48 hours in monolayer ± 10 μM GSI. Means plotted ± SEM, * P < 0.05, ** P < 0.01, *** P < 0.001 compared to E2 treated. # P < 0.05 compared to control cells.
Full Length Notch, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+notch1+icd/Notch1+XP+Rabbit+mAb/pmc06492532-82-11-15
Average 96 stars, based on 1 article reviews
full length notch - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology sc 32756 rabbit anti human notch1 ecd antibody
Systemic oestrogen signalling is mediated by EGFR and Notch . ( A ) Representative Western blot showing expression of cleaved (active) Notch1 <t>(N1-ICD)</t> following culture ± 1 nM 17β-estradiol ± 10 μM GSI. ( Bi ) Representative Western blot showing expression of Notch ligands in sorted MCF7 cells (left) and, where available, metastatic cells (right). ( Bii ) Densitometric analysis of three independent repeats of MCF7 sorting and of a single experiment for primary cells. Comparisons between population 1 (CSC enriched) and other populations are displayed. ( C and D ) Mammosphere formation was assessed following culture with 1 nM 17β-estradiol ± gamma secretase inhibitor (GSI) alone and in combination with gefitinib. Fold change is normalised to control, untreated cells represented as line. ( E ) Representative image of protein levels of ERK and phosphorylated (actived) ERK following culture for 48 hours in monolayer ± 10 μM GSI. Means plotted ± SEM, * P < 0.05, ** P < 0.01, *** P < 0.001 compared to E2 treated. # P < 0.05 compared to control cells.
Sc 32756 Rabbit Anti Human Notch1 Ecd Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+notch1+icd/Notch+1+Antibody/ppr0231070-93-27-33
Average 96 stars, based on 1 article reviews
sc 32756 rabbit anti human notch1 ecd antibody - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

90
Biocompare notch 1 icd antibody
Systemic oestrogen signalling is mediated by EGFR and Notch . ( A ) Representative Western blot showing expression of cleaved (active) Notch1 <t>(N1-ICD)</t> following culture ± 1 nM 17β-estradiol ± 10 μM GSI. ( Bi ) Representative Western blot showing expression of Notch ligands in sorted MCF7 cells (left) and, where available, metastatic cells (right). ( Bii ) Densitometric analysis of three independent repeats of MCF7 sorting and of a single experiment for primary cells. Comparisons between population 1 (CSC enriched) and other populations are displayed. ( C and D ) Mammosphere formation was assessed following culture with 1 nM 17β-estradiol ± gamma secretase inhibitor (GSI) alone and in combination with gefitinib. Fold change is normalised to control, untreated cells represented as line. ( E ) Representative image of protein levels of ERK and phosphorylated (actived) ERK following culture for 48 hours in monolayer ± 10 μM GSI. Means plotted ± SEM, * P < 0.05, ** P < 0.01, *** P < 0.001 compared to E2 treated. # P < 0.05 compared to control cells.
Notch 1 Icd Antibody, supplied by Biocompare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+notch1+icd/notch+1+icd+antibody/us11376259-113-8-25
Average 90 stars, based on 1 article reviews
notch 1 icd antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Figure 4. Sox17 expression is inversely regulated by Notch signaling. A, Immunofluorescence images for Sox17 (red) and green fluorescent protein (GFP; green) of human umbilical vein endothelial cells transfected with mock (control) or Notch1 intracellular domain (N1ICD) vector, which can express GPF simultaneously by a dual promoter system. Transfected cells are distinguished as GFP expression. Arrows highlight reduced Sox17 protein expression only in individual cells transfected with N1ICD vector but not in nontransfected cells. (B) Quantification of Sox17 protein expression in A. Images for Sox17 (red) and isolectin-B4 (IB4; green) of P5 retina. (C) Reduced Sox17 expression in N1ICDiGOF mutants. D, Increased Sox17- expressing endothelial cells on α-delta–like ligand 4 (Dll4) antibody treatment compared with IgG treatment. Scale bars, 100 μm. Ctrl indicates control.

Journal: Circulation Research

Article Title: Notch Pathway Targets Proangiogenic Regulator Sox17 to Restrict Angiogenesis

doi: 10.1161/circresaha.115.303142

Figure Lengend Snippet: Figure 4. Sox17 expression is inversely regulated by Notch signaling. A, Immunofluorescence images for Sox17 (red) and green fluorescent protein (GFP; green) of human umbilical vein endothelial cells transfected with mock (control) or Notch1 intracellular domain (N1ICD) vector, which can express GPF simultaneously by a dual promoter system. Transfected cells are distinguished as GFP expression. Arrows highlight reduced Sox17 protein expression only in individual cells transfected with N1ICD vector but not in nontransfected cells. (B) Quantification of Sox17 protein expression in A. Images for Sox17 (red) and isolectin-B4 (IB4; green) of P5 retina. (C) Reduced Sox17 expression in N1ICDiGOF mutants. D, Increased Sox17- expressing endothelial cells on α-delta–like ligand 4 (Dll4) antibody treatment compared with IgG treatment. Scale bars, 100 μm. Ctrl indicates control.

Article Snippet: In Vitro Modulation of Notch Signaling For in vitro activation of Notch signaling, human umbilical vein endothelial cells were transfected with EF.hICN1.CMV.GFP vector (17623, Addgene) containing human Notch1 intracellular domain or EF.CMV.RFP vector (17619, Addgene) as a negative control.

Techniques: Expressing, Immunofluorescence, Transfection, Control, Plasmid Preparation

Figure 6. Notch pathway regulates Sox17 expression mainly at the post-transcriptional level. Immunoblotting and quantification of Sox17 signal (A, C, E, G, I) and transcript level of Sox17 (B, D, F, H, J). A to D, Reduced Sox17 protein level on Notch activation. A and B, Human umbilical vein endothelial cells (HUVECs) transfected with control or Notch1 intracellular domain (N1ICD) vector (n=4). C and D, P5 lungs from control and N1ICDiGOF pups (n=3). E to J, Increased Sox17 protein level after Notch inactivation. E and F, HUVECs treated with vehicle (control) or N-[N-(3,5-difluorophenacetyl)-L-alanyl]–S-phenylglycine t-butylester (DAPT; n=4). G and H, P5 lungs treated with IgG or α-delta-like ligand 4 (Dll4) antibody (Ab; n≥3). I, Images showing Sox17 (red) and platelet endothelial cell adhesion molecule (PECAM; blue) of Lewis lung carcinoma tumors treated with IgG or α-Dll4 Ab. Quantification of Sox17 intensity in tumor vessels (n=20; right). J, Transcript level of Sox17 in tumor endothelial cells (tECs) of tumors treated with IgG or α-Dll4 Ab (n=3). Data are presented as mean±SD; #P<0.01; *P<0.05. Scale bars, 100 μm.

Journal: Circulation Research

Article Title: Notch Pathway Targets Proangiogenic Regulator Sox17 to Restrict Angiogenesis

doi: 10.1161/circresaha.115.303142

Figure Lengend Snippet: Figure 6. Notch pathway regulates Sox17 expression mainly at the post-transcriptional level. Immunoblotting and quantification of Sox17 signal (A, C, E, G, I) and transcript level of Sox17 (B, D, F, H, J). A to D, Reduced Sox17 protein level on Notch activation. A and B, Human umbilical vein endothelial cells (HUVECs) transfected with control or Notch1 intracellular domain (N1ICD) vector (n=4). C and D, P5 lungs from control and N1ICDiGOF pups (n=3). E to J, Increased Sox17 protein level after Notch inactivation. E and F, HUVECs treated with vehicle (control) or N-[N-(3,5-difluorophenacetyl)-L-alanyl]–S-phenylglycine t-butylester (DAPT; n=4). G and H, P5 lungs treated with IgG or α-delta-like ligand 4 (Dll4) antibody (Ab; n≥3). I, Images showing Sox17 (red) and platelet endothelial cell adhesion molecule (PECAM; blue) of Lewis lung carcinoma tumors treated with IgG or α-Dll4 Ab. Quantification of Sox17 intensity in tumor vessels (n=20; right). J, Transcript level of Sox17 in tumor endothelial cells (tECs) of tumors treated with IgG or α-Dll4 Ab (n=3). Data are presented as mean±SD; #P<0.01; *P<0.05. Scale bars, 100 μm.

Article Snippet: In Vitro Modulation of Notch Signaling For in vitro activation of Notch signaling, human umbilical vein endothelial cells were transfected with EF.hICN1.CMV.GFP vector (17623, Addgene) containing human Notch1 intracellular domain or EF.CMV.RFP vector (17619, Addgene) as a negative control.

Techniques: Expressing, Western Blot, Activation Assay, Transfection, Control, Plasmid Preparation

NO sustains CSC stemness through the activation of Notch1. (A) Immunoblot analysis of Notch1 and Hes1 protein in non‐CSCs and CSCs. (B) The protein expression of Notch1 was analysed in non‐CSCs treated with DETA NONOate (20 μM) for 24 h. (C) CSCs were treated with L‐NAME for 24 h and detected for Notch1 protein with immunoblots. (D, E) CSCs were treated with L‐NAME (100 μM)/1400 W (100 μM) in the presence or absence of the DETA NONOate (20 μM)/GSNO (200 μM) for 24 h. Protein expression of Notch1 and Hes1 were detected by immunoblot. (F–H) CSCs were exposed to L‐NAME (100 μM) with or without the reintroduction of NICD and were analysed for expression of Notch1 protein, stem‐related transcripts and spheres formation. Mean ± SEM from 5 to 9 independent experiments. * p < 0.05, ** p < 0.01 and *** p < 0.001 with paired t ‐test (B, C), unpaired t ‐test (A) and ANOVA plus Turkey's method (D, G, H).

Journal: Journal of Cellular and Molecular Medicine

Article Title: Nitric oxide facilitates the S‐nitrosylation and deubiquitination of Notch1 protein to maintain cancer stem cells in human NSCLC

doi: 10.1111/jcmm.70203

Figure Lengend Snippet: NO sustains CSC stemness through the activation of Notch1. (A) Immunoblot analysis of Notch1 and Hes1 protein in non‐CSCs and CSCs. (B) The protein expression of Notch1 was analysed in non‐CSCs treated with DETA NONOate (20 μM) for 24 h. (C) CSCs were treated with L‐NAME for 24 h and detected for Notch1 protein with immunoblots. (D, E) CSCs were treated with L‐NAME (100 μM)/1400 W (100 μM) in the presence or absence of the DETA NONOate (20 μM)/GSNO (200 μM) for 24 h. Protein expression of Notch1 and Hes1 were detected by immunoblot. (F–H) CSCs were exposed to L‐NAME (100 μM) with or without the reintroduction of NICD and were analysed for expression of Notch1 protein, stem‐related transcripts and spheres formation. Mean ± SEM from 5 to 9 independent experiments. * p < 0.05, ** p < 0.01 and *** p < 0.001 with paired t ‐test (B, C), unpaired t ‐test (A) and ANOVA plus Turkey's method (D, G, H).

Article Snippet: Human Notch1 intracellular domain plasmid (#130934) was from Addgene.

Techniques: Activation Assay, Western Blot, Expressing

NO inhibits the ubiquitination of Notch1. (A) mRNA level of Notch1 was measured in CSCs with or without L‐NAME (100 μM) treatment for 24 h. Mean ± SEM from four independent experiments. (B) Notch1 cleavage‐related mRNA expressions in non‐CSCs and CSCs was determined with qPCR. Mean ± SEM from six independent experiments. (C) CSCs were treated with or without L‐NAME (100 μM) for 24 h and detected for Notch1 cleavage‐related mRNA expressions by qPCR. Mean ± SEM from 6 to 8 independent experiments. (D) CSCs were treated with L‐NAME (100 μM) in the presence or absence of the MG132 (10 μM) for 4 h. Protein expression of Notch1 was detected by immunoblot. Mean ± SEM from four independent experiments. (E) Notch1 ubiquitination in non‐CSCs and CSCs was analysed using endogenous immunoprecipitated Notch1 protein. * p < 0.05, ** p < 0.01 with paired t ‐test (A, C), unpaired t ‐test (B) and ANOVA plus Turkey's method (D).

Journal: Journal of Cellular and Molecular Medicine

Article Title: Nitric oxide facilitates the S‐nitrosylation and deubiquitination of Notch1 protein to maintain cancer stem cells in human NSCLC

doi: 10.1111/jcmm.70203

Figure Lengend Snippet: NO inhibits the ubiquitination of Notch1. (A) mRNA level of Notch1 was measured in CSCs with or without L‐NAME (100 μM) treatment for 24 h. Mean ± SEM from four independent experiments. (B) Notch1 cleavage‐related mRNA expressions in non‐CSCs and CSCs was determined with qPCR. Mean ± SEM from six independent experiments. (C) CSCs were treated with or without L‐NAME (100 μM) for 24 h and detected for Notch1 cleavage‐related mRNA expressions by qPCR. Mean ± SEM from 6 to 8 independent experiments. (D) CSCs were treated with L‐NAME (100 μM) in the presence or absence of the MG132 (10 μM) for 4 h. Protein expression of Notch1 was detected by immunoblot. Mean ± SEM from four independent experiments. (E) Notch1 ubiquitination in non‐CSCs and CSCs was analysed using endogenous immunoprecipitated Notch1 protein. * p < 0.05, ** p < 0.01 with paired t ‐test (A, C), unpaired t ‐test (B) and ANOVA plus Turkey's method (D).

Article Snippet: Human Notch1 intracellular domain plasmid (#130934) was from Addgene.

Techniques: Ubiquitin Proteomics, Expressing, Western Blot, Immunoprecipitation

NO inhibits the ubiquitination of Notch1 by facilitating its interaction with UCHL1. (A) Potential DUBs and E3 ligase of Notch1 obtained from the UbiBrowser database. (B, C) DUBs and E3 ligase mRNA expressions in non‐CSCs and CSCs were determined with qPCR. Mean ± SEM from six independent experiments. (D) Immunoblot analysis of UCHL1 protein in non‐CSCs and CSCs. Mean ± SEM from five independent experiments. (E) Co‐immunoprecipitation analysis of Notch1‐UCHL1 interaction in non‐CSCs and CSCs. (F) Genetic knockdown efficiency of UCHL1 in CSCs by lentiviral shRNA transfections. Mean ± SEM from four independent experiments. (G) Immunoblot analysis of Notch1 protein in CSCs transfected with or without the independent UCHL1 shRNAs. Mean ± SEM from four independent experiments. (H) Genetic knockdown efficiency of WWP1, MDM2, USP9X and PSMD7 in CSCs by lentiviral shRNA transfections. Mean ± SEM from 4 to 6 independent experiments. (I) Immunoblot analysis of Notch1 protein in CSCs transfected with or without the independent WWP1, MDM2, USP9X and PSMD7 shRNAs. (J) Immunoprecipitation analysis of ubiquitination of Notch1 in CSCs that were transfected with shUCHL1. (K) CSCs were transfected with UCHL1 shRNAs in the presence or absence of the DETA NONOate (20 μM). The protein of Notch1 was analysed with immunoblot. Mean ± SEM from four independent experiments. (L) Immunoprecipitation analysis of Notch1 ubiquitination in CSCs that were transfected with UCHL1 shRNAs together with DETA NONOate (20 μM). (M) CSCs transfected with UCHL1 shRNAs were analysed for expression of stem‐related transcripts. Mean ± SEM from 5 to 6 independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001 and **** p < 0.0001 with paired t ‐test (M) and ANOVA plus Turkey's method (F–H, K).

Journal: Journal of Cellular and Molecular Medicine

Article Title: Nitric oxide facilitates the S‐nitrosylation and deubiquitination of Notch1 protein to maintain cancer stem cells in human NSCLC

doi: 10.1111/jcmm.70203

Figure Lengend Snippet: NO inhibits the ubiquitination of Notch1 by facilitating its interaction with UCHL1. (A) Potential DUBs and E3 ligase of Notch1 obtained from the UbiBrowser database. (B, C) DUBs and E3 ligase mRNA expressions in non‐CSCs and CSCs were determined with qPCR. Mean ± SEM from six independent experiments. (D) Immunoblot analysis of UCHL1 protein in non‐CSCs and CSCs. Mean ± SEM from five independent experiments. (E) Co‐immunoprecipitation analysis of Notch1‐UCHL1 interaction in non‐CSCs and CSCs. (F) Genetic knockdown efficiency of UCHL1 in CSCs by lentiviral shRNA transfections. Mean ± SEM from four independent experiments. (G) Immunoblot analysis of Notch1 protein in CSCs transfected with or without the independent UCHL1 shRNAs. Mean ± SEM from four independent experiments. (H) Genetic knockdown efficiency of WWP1, MDM2, USP9X and PSMD7 in CSCs by lentiviral shRNA transfections. Mean ± SEM from 4 to 6 independent experiments. (I) Immunoblot analysis of Notch1 protein in CSCs transfected with or without the independent WWP1, MDM2, USP9X and PSMD7 shRNAs. (J) Immunoprecipitation analysis of ubiquitination of Notch1 in CSCs that were transfected with shUCHL1. (K) CSCs were transfected with UCHL1 shRNAs in the presence or absence of the DETA NONOate (20 μM). The protein of Notch1 was analysed with immunoblot. Mean ± SEM from four independent experiments. (L) Immunoprecipitation analysis of Notch1 ubiquitination in CSCs that were transfected with UCHL1 shRNAs together with DETA NONOate (20 μM). (M) CSCs transfected with UCHL1 shRNAs were analysed for expression of stem‐related transcripts. Mean ± SEM from 5 to 6 independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001 and **** p < 0.0001 with paired t ‐test (M) and ANOVA plus Turkey's method (F–H, K).

Article Snippet: Human Notch1 intracellular domain plasmid (#130934) was from Addgene.

Techniques: Ubiquitin Proteomics, Western Blot, Immunoprecipitation, Knockdown, shRNA, Transfection, Expressing

NO‐facilitated s‐nitrosylation of Notch1 promotes its binding to UCHL1. (A) Biotin switch assay was employed to detect the SNO‐Notch1 levels in both non‐CSCs and CSCs. (B) The SNO‐Notch1 level in DETA NONOate‐treated (20 μM, 24 h) CSCs were detected by biotin switch assay. (C) The SNO‐Notch1 level in L‐NAME‐treated (100 μM, 24 h) CSCs were detected by biotin switch assay. (D) Notch1 protein levels in CSCs with or without ODQ (10 μM, 24 h) were analysed by immunoblotting. Mean ± SEM from four independent experiments. (E) Immunoprecipitation analysis of Notch1 ubiquitination in CSCs in the presence or absence of L‐NAME (100 μM) for 24 h. (F) Immunoprecipitation analysis of Notch1 ubiquitination in CSCs treated with DETA NONOate (20 μM) for 24 h. (G) Co‐immunoprecipitation analysis of Notch1 and UCHL1 interaction in CSCs in the presence or absence of DETA NONOate (20 μM). (H) Co‐immunoprecipitation analysis of Notch1 and UCHL1 interaction in CSCs with or without L‐NAME (100 μM).

Journal: Journal of Cellular and Molecular Medicine

Article Title: Nitric oxide facilitates the S‐nitrosylation and deubiquitination of Notch1 protein to maintain cancer stem cells in human NSCLC

doi: 10.1111/jcmm.70203

Figure Lengend Snippet: NO‐facilitated s‐nitrosylation of Notch1 promotes its binding to UCHL1. (A) Biotin switch assay was employed to detect the SNO‐Notch1 levels in both non‐CSCs and CSCs. (B) The SNO‐Notch1 level in DETA NONOate‐treated (20 μM, 24 h) CSCs were detected by biotin switch assay. (C) The SNO‐Notch1 level in L‐NAME‐treated (100 μM, 24 h) CSCs were detected by biotin switch assay. (D) Notch1 protein levels in CSCs with or without ODQ (10 μM, 24 h) were analysed by immunoblotting. Mean ± SEM from four independent experiments. (E) Immunoprecipitation analysis of Notch1 ubiquitination in CSCs in the presence or absence of L‐NAME (100 μM) for 24 h. (F) Immunoprecipitation analysis of Notch1 ubiquitination in CSCs treated with DETA NONOate (20 μM) for 24 h. (G) Co‐immunoprecipitation analysis of Notch1 and UCHL1 interaction in CSCs in the presence or absence of DETA NONOate (20 μM). (H) Co‐immunoprecipitation analysis of Notch1 and UCHL1 interaction in CSCs with or without L‐NAME (100 μM).

Article Snippet: Human Notch1 intracellular domain plasmid (#130934) was from Addgene.

Techniques: Binding Assay, Biotin Switch Assay, Western Blot, Immunoprecipitation, Ubiquitin Proteomics

Targeting UCHL1 and NO downregulates the expression levels of Notch1 and CD133. (A) Representative of PDO‐primary tumour pair with immunostaining for CD31. Nuclei were stained with Hoechst. Scale bar, 20 μm. (B) Representative of PDO‐primary tumour pair with immunostaining for PanCK. Nuclei were stained with Hoechst. Scale bar, 20 μm. (C) Representative HE staining of PDO‐primary tumour pairs. Scale bars, 100 μm. (D, E) PDOs treated with or without DETA NONOate (20 μM) were analysed for CD133 and Notch1 protein. Representatives from six independent experiments. (F, G) PDOs were transfected with UCHL1 shRNAs in the presence or absence of the DETA NONOate (20 μM), followed by analysis of CD133 and Notch1 protein. Representatives from 4 to 5 independent experiments. (H, I) PDOs exposed to 10 Gy x‐rays were treated with L‐NAME (100 μM), followed by analysis of CD133 and Notch1 protein. Representatives from 3 to 5 independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 with paired t ‐test (D, E) and ANOVA plus Turkey's method (F–I).

Journal: Journal of Cellular and Molecular Medicine

Article Title: Nitric oxide facilitates the S‐nitrosylation and deubiquitination of Notch1 protein to maintain cancer stem cells in human NSCLC

doi: 10.1111/jcmm.70203

Figure Lengend Snippet: Targeting UCHL1 and NO downregulates the expression levels of Notch1 and CD133. (A) Representative of PDO‐primary tumour pair with immunostaining for CD31. Nuclei were stained with Hoechst. Scale bar, 20 μm. (B) Representative of PDO‐primary tumour pair with immunostaining for PanCK. Nuclei were stained with Hoechst. Scale bar, 20 μm. (C) Representative HE staining of PDO‐primary tumour pairs. Scale bars, 100 μm. (D, E) PDOs treated with or without DETA NONOate (20 μM) were analysed for CD133 and Notch1 protein. Representatives from six independent experiments. (F, G) PDOs were transfected with UCHL1 shRNAs in the presence or absence of the DETA NONOate (20 μM), followed by analysis of CD133 and Notch1 protein. Representatives from 4 to 5 independent experiments. (H, I) PDOs exposed to 10 Gy x‐rays were treated with L‐NAME (100 μM), followed by analysis of CD133 and Notch1 protein. Representatives from 3 to 5 independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 with paired t ‐test (D, E) and ANOVA plus Turkey's method (F–I).

Article Snippet: Human Notch1 intracellular domain plasmid (#130934) was from Addgene.

Techniques: Expressing, Immunostaining, Staining, Transfection

NICD protein and NICD-dependent transcripts are more abundant in Fbw7-/- embryos. (A) Western blots using indicated antibodies against whole embryo lysates. The loading control (LC*) is a cross-reactive band. (B) Relative levels of Notch 1 mRNA by real-time PCR using SYBR-green detection of mRNA prepared from embryos and placenta of the indicated genotypes. (C) Relative levels of the Notch-dependent transcripts Hes1, Herp1, and Herp2 in Fbw7+/+ and Fbw7-/- embryos by using quantitative real-time PCR analysis as in B.

Journal:

Article Title: Defective cardiovascular development and elevated cyclin E and Notch proteins in mice lacking the Fbw7 F-box protein

doi: 10.1073/pnas.0307875101

Figure Lengend Snippet: NICD protein and NICD-dependent transcripts are more abundant in Fbw7-/- embryos. (A) Western blots using indicated antibodies against whole embryo lysates. The loading control (LC*) is a cross-reactive band. (B) Relative levels of Notch 1 mRNA by real-time PCR using SYBR-green detection of mRNA prepared from embryos and placenta of the indicated genotypes. (C) Relative levels of the Notch-dependent transcripts Hes1, Herp1, and Herp2 in Fbw7+/+ and Fbw7-/- embryos by using quantitative real-time PCR analysis as in B.

Article Snippet: Antibodies used to detect blotted proteins were as follows: anti-cyclin E (M20, Santa Cruz Biotechnology), Notch1 ICD (Cell Signaling Technology, Beverly, MA), Notch3 ICD (Upstate Biotechnology, Lake Placid, NY), p107 (Santa Cruz Biotechnology) and Notch4 ICD (Upstate Biotechnology).

Techniques: Western Blot, Real-time Polymerase Chain Reaction, SYBR Green Assay

Systemic oestrogen signalling is mediated by EGFR and Notch . ( A ) Representative Western blot showing expression of cleaved (active) Notch1 (N1-ICD) following culture ± 1 nM 17β-estradiol ± 10 μM GSI. ( Bi ) Representative Western blot showing expression of Notch ligands in sorted MCF7 cells (left) and, where available, metastatic cells (right). ( Bii ) Densitometric analysis of three independent repeats of MCF7 sorting and of a single experiment for primary cells. Comparisons between population 1 (CSC enriched) and other populations are displayed. ( C and D ) Mammosphere formation was assessed following culture with 1 nM 17β-estradiol ± gamma secretase inhibitor (GSI) alone and in combination with gefitinib. Fold change is normalised to control, untreated cells represented as line. ( E ) Representative image of protein levels of ERK and phosphorylated (actived) ERK following culture for 48 hours in monolayer ± 10 μM GSI. Means plotted ± SEM, * P < 0.05, ** P < 0.01, *** P < 0.001 compared to E2 treated. # P < 0.05 compared to control cells.

Journal: Breast Cancer Research : BCR

Article Title: Oestrogen increases the activity of oestrogen receptor negative breast cancer stem cells through paracrine EGFR and Notch signalling

doi: 10.1186/bcr3396

Figure Lengend Snippet: Systemic oestrogen signalling is mediated by EGFR and Notch . ( A ) Representative Western blot showing expression of cleaved (active) Notch1 (N1-ICD) following culture ± 1 nM 17β-estradiol ± 10 μM GSI. ( Bi ) Representative Western blot showing expression of Notch ligands in sorted MCF7 cells (left) and, where available, metastatic cells (right). ( Bii ) Densitometric analysis of three independent repeats of MCF7 sorting and of a single experiment for primary cells. Comparisons between population 1 (CSC enriched) and other populations are displayed. ( C and D ) Mammosphere formation was assessed following culture with 1 nM 17β-estradiol ± gamma secretase inhibitor (GSI) alone and in combination with gefitinib. Fold change is normalised to control, untreated cells represented as line. ( E ) Representative image of protein levels of ERK and phosphorylated (actived) ERK following culture for 48 hours in monolayer ± 10 μM GSI. Means plotted ± SEM, * P < 0.05, ** P < 0.01, *** P < 0.001 compared to E2 treated. # P < 0.05 compared to control cells.

Article Snippet: Primary antibodies included: SP1-ER (RM-9101-SO, Thermo Fisher Scientific, Basingstoke, UK), Cleaved N1-ICD (100-401-407, Rockland, Gilbertsville, USA), Delta1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA, sc-12530), Delta4 (Abcam, Cambridge, UK, ab7280), Jagged1 (Santa Cruz Biotechnology, sc-6011), Jagged2 (Santa Cruz Biotechnology, sc-08157), Actin (Santa Cruz Biotechnology, sc-1616), ERK (Abcam, ab2430) and ERK phospho-Y992 (Abcam, ab81440).

Techniques: Western Blot, Expressing, Control